Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

DSGNDSGN
22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in DESIGN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 81,971 shares of DSGN (DESIGN THERAPEUTICS INC), worth $1.2M as of 2026-Q2. The position was decreased (-64.6% shares). DSGN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.2M

Current Shares

81,971

Total Value Change

-$74.6M

Total Shares Change

-2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
81,971
-64.6%
$1.2M0.0%$14.47
0
2026-Q1
Decreased
231,513
-49.7%
$2.5M0.0%$10.00
0
2025-Q4
Decreased
459,874
-17.0%
$4.3M0.0%$9.79
0
2025-Q3
Decreased
554,020
-34.1%
$4.2M0.0%$6.85
0
2025-Q2
Decreased
840,793
-12.7%
$2.8M0.0%$3.57
0
2025-Q1
Increased
963,460
+0.5%
$3.7M0.0%$4.21
27
2024-Q4
Increased
958,793
+66.6%
$5.9M0.0%$6.17
40
2024-Q3
Increased
575,550
+88.9%
$3.1M0.0%$5.33
41
2024-Q2
Decreased
304,630
-65.2%
$1M0.0%$3.35
0
2024-Q1
Decreased
874,777
-52.3%
$3.5M0.0%$4.03
0
2023-Q4
Decreased
1.8M
-32.1%
$4.9M0.0%$2.65
0
2023-Q3
Decreased
2.7M
-5.5%
$6.4M0.0%$2.36
0
2023-Q2
Decreased
2.9M
-0.3%
$18M0.0%$5.82
0
2023-Q1
Increased
2.9M
+14.5%
$16.5M0.0%$5.70
32
2022-Q4
Increased
2.5M
+3.3%
$25.7M0.0%$10.26
30
2022-Q3
Decreased
2.4M
-4.9%
$40.5M0.0%$16.79
0
2022-Q2
Increased
2.5M
+0.4%
$35.6M0.0%$14.02
29
2022-Q1
Unchanged
2.5M
0.0%
$40.9M0.0%$16.01
0
2021-Q4
Decreased
2.5M
-1.5%
$54.3M0.0%$21.29
0
2021-Q3
Increased
2.6M
+0.3%
$37.8M0.0%$13.99
29
2021-Q2
Increased
2.6M
+1.2%
$49.9M0.0%$21.71
30
2021-Q1
New
2.5M
-
$75.8M0.0%$29.52
41

Other major holders of DSGN: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used